NIPRO JMI Pharma Ltd.
| Established | 2012 |
| Market Share | 1.19% |
| Growth | 21.82% |
| Total generics | 122 |
| Headquarter | Unique Heights (Level-6), 117, Kazi Nazrul Islam Avenue Dhaka-1217. |
| Contact details | 55138726, 55138727, 55138728 |
| Fax | 88-0255138725 |
NIPRO JMI Pharma Ltd (NJPL) is one of the robust and reputed pharmaceutical companies in Bangladesh. NIPRO JMI Pharma started its journey in 2012 with collaboration of NIPRO Corporation, a big giant MNC (Multinational Company) based in Japan. We are engaged in manufacturing and marketing of pharmaceuticals products in compliance with cGMP by WHO (World Health Organization).
NJP is dedicated to ensure its world class products and services through HCP (Healthcare professional) for the ailing humanity of the country and beyond. We focus on innovative ideas into our practices. We want to make our organization a national healthcare brand with global magnitude.
NJP is dedicated to ensure its world class products and services through HCP (Healthcare professional) for the ailing humanity of the country and beyond. We focus on innovative ideas into our practices. We want to make our organization a national healthcare brand with global magnitude.
Top brands
Doxiva
Doxophylline
Empa
Empagliflozin
Bilfast
Bilastine
Receca
Racecadotril
Lijenta-M
Linagliptin + Metformin Hydrochloride
Avamist
Fluticasone Furoate
EmpaMet
Empagliflozin + Metformin Hydrochloride
Lijenta
Linagliptin
V3N
Vitamin B1, B6 & B12
Pandura
Clonazepam
Fibritor
Pemafibrate
Lyrinex CR
Pregabalin
Irobest
Iron Polymaltose Complex + Folic Acid + Zinc Sulfate
Emjenta
Empagliflozin + Linagliptin
Betnova-N
Betamethasone + Neomycin Sulphate (Topical)
Nimovo
Naproxen Sodium + Esomeprazole Magnesium
Fibrocon
Resmetirom
Azaltic
Azithromycin Dihydrate
Cialix
Tadalafil
Calgi-D
Algae Calcium + Vitamin D3



